Literature DB >> 29154808

Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms.

Michiel C Mommersteeg1, Jun Yu2, Maikel P Peppelenbosch3, Gwenny M Fuhler4.   

Abstract

Helicobacter Pylori is a gram negative rod shaped microaerophilic bacterium that colonizes the stomach of approximately half the world's population. Infection with c may cause chronic gastritis which via a quite well described process known as Correas cascade can progress through sequential development of atrophic gastritis, intestinal metaplasia and dysplasia to gastric cancer. H. pylori is currently the only bacterium that is classified as a class 1 carcinogen by the WHO, although the exact mechanisms by which this bacterium contributes to gastric carcinogenesis are still poorly understood. Only a minority of H. pylori-infected patients will eventually develop gastric cancer, suggesting that host factors may be important in determining the outcome of H. pylori infection. This is supported by a growing body of evidence suggesting that the host genetic background contributes to risk of H. pylori infection and gastric carcinogenesis. In particular single nucleotide polymorphisms in genes that influence bacterial handling via pattern recognition receptors appear to be involved, further strengthening the link between host risk factors, H. pylori incidence and cancer. Many of these genes influence cellular pathways leading to inflammatory signaling, inflammasome formation and autophagy. In this review we summarize known carcinogenic effects of H. pylori, and discuss recent findings that implicate host genetic pattern recognition pathways in the development of gastric cancer and their relation with H. pylori.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Helicobacter pylori; NOD-like receptor; Polymorphism single nucleotide; Stomach neoplasms; Toll-like receptors

Mesh:

Year:  2017        PMID: 29154808     DOI: 10.1016/j.bbcan.2017.11.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  21 in total

1.  Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori.

Authors:  Yuan-Yuan Dai; Chun Qin; Gan-Rong Huang; Yan-Chun Qin; Yong-Yi Huang; Yan-Qiang Huang; Li-Juan Zhao
Journal:  Antimicrob Agents Chemother       Date:  2022-06-27       Impact factor: 5.938

Review 2.  Crosstalks between inflammasome and autophagy in cancer.

Authors:  Chaeuk Chung; Wonhyoung Seo; Prashanta Silwal; Eun-Kyeong Jo
Journal:  J Hematol Oncol       Date:  2020-07-23       Impact factor: 17.388

3.  Relationship between Helicobacter pylori and expression of programmed death-1 and its ligand in gastric intraepithelial neoplasia and early-stage gastric cancer.

Authors:  Bo Shen; Aihua Qian; Wenji Lao; Weiguang Li; Xi Chen; Benyan Zhang; Huafeng Wang; Fei Yuan; Yunwei Sun
Journal:  Cancer Manag Res       Date:  2019-05-02       Impact factor: 3.989

4.  Helicobacter pylori Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania.

Authors:  Hyasinta Jaka; Nele Rüttgerodt; Wolfgang Bohne; Andreas Mueller; Uwe Gross; Christa Kasang; Stephen E Mshana
Journal:  Can J Gastroenterol Hepatol       Date:  2019-07-01

5.  The Prevalence of Helicobacter Pylori babA, homB, aspA, and sabA Genes and Its Relationship with Clinical Outcomes in Turkey.

Authors:  Nimet Yılmaz; Meltem Koruk Özer
Journal:  Can J Gastroenterol Hepatol       Date:  2019-06-13

Review 6.  New insights of Helicobacter pylori host-pathogen interactions: The triangle of virulence factors, epigenetic modifications and non-coding RNAs.

Authors:  Farzam Vaziri; Samira Tarashi; Abolfazl Fateh; Seyed Davar Siadat
Journal:  World J Clin Cases       Date:  2018-05-16       Impact factor: 1.337

7.  Toll-like receptor 9 polymorphisms and Helicobacter pylori influence gene expression and risk of gastric carcinogenesis in the Brazilian population.

Authors:  Manoela Dias Susi; de Matos Lourenço Caroline; Lucas Trevizani Rasmussen; Spencer Luis Marques Payão; Ana Flávia Teixeira Rossi; Ana Elizabete Silva; Juliana Garcia de Oliveira-Cucolo
Journal:  World J Gastrointest Oncol       Date:  2019-11-15

8.  Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication.

Authors:  Joseph J Y Sung; Olabisi Oluwabukola Coker; Eagle Chu; Chun Ho Szeto; Simson Tsz Yat Luk; Harry Cheuk Hay Lau; Jun Yu
Journal:  Gut       Date:  2020-01-23       Impact factor: 23.059

9.  USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis.

Authors:  Lionel Costa; Sébastien Corre; Valérie Michel; Krysten Le Luel; Julien Fernandes; Jason Ziveri; Gregory Jouvion; Anne Danckaert; Nicolas Mouchet; David Da Silva Barreira; Javier Torres; Margarita Camorlinga; Mario Milco D'Elios; Laurence Fiette; Hilde De Reuse; Marie-Dominique Galibert; Eliette Touati
Journal:  Gut       Date:  2019-12-10       Impact factor: 23.059

10.  Characterization and strong risk association of TLR2 del -196 to -174 polymorphism and Helicobacter pylori and their influence on mRNA expression in gastric cancer.

Authors:  Caroline de Matos Lourenço; Manoela Dias Susi; Mariah Cristina Antunes do Nascimento; Vilson Serafim Junior; Ana Paula Simedan Vila; Gabriela Helena Rodrigues-Flemming; Eny Maria Goloni-Bertollo; Ana Elizabete Silva; Juliana Garcia de Oliveira-Cucolo
Journal:  World J Gastrointest Oncol       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.